問卷

TPIDB > Principal Investigator

Principal Investigator


Taipei Veterans General Hospital (在職)

Division of General Surgery

Division of Hematology & Oncology

Division of Thoracic Surgery

Division of Thoracic Medicine

Division of Anesthesia

Taipei Medical University Hospital (在職)

Division of Thoracic Surgery

Division of Thoracic Medicine

更新時間:2023-09-19

吳玉琮Wu, Yu-Chung
  • Co-Principal Investigator
  • Clinical Trial Experience (year) 12 years 9 個月

篩選

List

1Cases

2018-11-02 - 2028-12-31

Phase III

Active
A Phase III, Double-blind, Placebo controlled, Multi-center International Study of Neoadjuvant/adjuvant Durvalumab for the Treatment of Patients with Resectable Stages II and III Non-small Cell Lung Cancer (AEGEAN)
  • Condition/Disease

    Neoadjuvant/adjuvant Durvalumab for the Treatment of Patients with Resectable Stages II and III Non-small Cell Lung Cancer

  • Test Drug

    Durvalumab (MEDI4736)

Participate Sites
9Sites

Recruiting6Sites

Terminated3Sites